Qube Research & Technologies (QRT)
DMRA

Qube Research & Technologies (QRT)’s Damora Therapeutics, Inc. Ordinary Shares DMRA Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio DMRA Stock Details DMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.32M Buy
+282,436
New +$7.26M 0.01% 1469

Other funds holding DMRA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
RCP
Remedium Capital Partners Fort Lauderdale, Florida $281M AUM

Qube Research & Technologies (QRT)'s DMRA Position: Q1 2026 in Review

Qube Research & Technologies (QRT) opened a new position in Damora Therapeutics, Inc. Ordinary Shares (DMRA) in Q1 2026: 282,436 shares worth $7.32M. The stake represents 0.01% of the portfolio and ranks #1469 among its holdings.

65 funds tracked by Wall St. Rank hold DMRA as of Q1 2026.

  • Qube Research & Technologies (QRT) held 282,436 shares of Damora Therapeutics, Inc. Ordinary Shares worth $7.32M as of Q1 2026.
  • Damora Therapeutics, Inc. Ordinary Shares was a new Qube Research & Technologies (QRT) position in Q1 2026.
  • Damora Therapeutics, Inc. Ordinary Shares made up 0.01% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #1469 holding.
  • 65 funds tracked by Wall St. Rank held Damora Therapeutics, Inc. Ordinary Shares as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.